2 recruiting, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 1 | Completed 1 |
Follow Eganelisib: new trials by email Literature Review of Eganelisib trials Research Report on Eganelisib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia Eganelisib, Azacitidine, Venetoclax - Leukemia, Myeloid, Leukemia | Phase 1 | Recruiting | Jacqueline Garcia, MD | 48 | 2026-04-13 | 2026-08-26 |
| Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS Eganelisib, Eganelisib in combination with cytarabine, Eganelisib in combination with azacitidine - AML, Adult, MDS | Phase 1 | Recruiting | Stelexis BioSciences | 105 | 2025-04-28 | 2026-10-20 |
| IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma IPI-549 - Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer | Phase 2 | Completed | Assuntina G. Sacco, MD | 16 | 2020-03-06 | 2025-07-25 |
Leukemia, Myeloid, Acute (2) · Carcinoma (1) · Head and Neck Neoplasms (1) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Assuntina G. Sacco, MD (1) · Jacqueline Garcia, MD (1) · Stelexis BioSciences (1)
United States (3) · Spain (1)
Ezra Cohen, MD (1) · Jacqueline Garcia, MD (1)